Results 191 to 200 of about 2,995,978 (218)

Less Cytotoxic Protoflavones as Antiviral Agents: Protoapigenone 1'-O-isopropyl ether Shows Improved Selectivity Against the Epstein-Barr Virus Lytic Cycle. [PDF]

open access: yesInt J Mol Sci, 2019
Vágvölgyi M   +11 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Epstein-Barr Virus Lytic Cycle Reactivation.

Current Topics in Microbiology and Immunology, 2015
Epstein-Barr virus, which mainly infects B cells and epithelial cells, has two modes of infection: latent and lytic. Epstein-Barr virus infection is predominantly latent; however, lytic infection is detected in healthy seropositive individuals and becomes more prominent in certain pathological conditions. Lytic infection is divided into several stages:
Jessica McKenzie, A. El-Guindy
semanticscholar   +3 more sources

Genipin as a novel chemical activator of EBV lytic cycle

Journal of Microbiology, 2015
Epstein-Barr virus (EBV) is a ubiquitous gammaherpesvirus that causes acute infection and establishes life-long latency. EBV causes several human cancers, including Burkitt's lymphoma, nasopharyngeal and gastric carcinoma. Antiviral agents can be categorized as virucides, antiviral chemotherapeutic agents, and immunomodulators.
Myoungki Son   +9 more
semanticscholar   +4 more sources

Home - About - Disclaimer - Privacy